1 Obscure Marijuana Stock That Could Earn You 100%

Cannabis investors should look beyond the industry leaders that continue to disappoint. The obscure OrganiGram stock could turn out to be the best-in-class pot stock and earn you 100% in 2021.

| More on:
edit Jars of marijuana

Image source: Getty Images

Canadian cannabis producers have been itching to penetrate the lucrative U.S. markets. The companies pin their hopes on lawmakers that would champion the federalization of marijuana. So, President Joe Biden’s win was welcome news because Democrats support the decriminalization of marijuana.

The cannabis sector rallied in February 2021 but most stocks have fallen after due to several challenges. In the recent earnings season, industry leader Canopy Growth and peers Aurora Cannabis and Cronos reported disappointing results. In addition, the merger of Aphria and Tilray did little to boost weed stocks.

Most investors look to big industry players to gain exposure to the cannabis space that should grow by around 18% annually between last year and 2027. However, one obscure marijuana stock could deliver much more gains than the top names. OrganiGram (TSX:OGI)(NASDAQ:OGI) remains a speculative play, although if it can execute its growth plans well, it can hold its own against larger peers.

Competing bills

The Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act sponsored by then-senator and now Vice-President Kamala Harris was reintroduced at the U.S. Senate in late May 2021. The MORE Act proposes to remove cannabis from the federal Controlled Substances Act.

Republican congressmen Dave Joyce and Don Young sponsored a competing bill known as the Common Sense Cannabis Reform for Veterans, Small Businesses, and Medical Professionals Act. Both Houses of Congress are making moves to fast-track the legalization of marijuana at the federal level.

Waiting game

However, it could take months before either bill gets a hearing. The Democrats and Republicans might need to find a compromise that should also be acceptable to the marijuana industry. In 2019, the House passed the SAFE Banking Act which gives protections for depository institutions providing financial services to cannabis-related businesses.

Canadian cannabis producers would have to wait a little more for full-scale federal legalization across the border. After that, politics could rear its ugly head and extend the suspense. Once the legal hurdles are over, industry experts estimate the annual market value of cannabis to reach US$30 billion by 2025.

Potential best-in-class MJ stock

OrganiGram is pint-sized compared to industry leader Canopy Growth. However, the $1.1 billion producer and seller of cannabis and cannabis-derived products from Moncton could be the best-in-class marijuana stock. Thus far, in 2021, the small player outperforms Canopy, +120.12% versus -6.48%. The current share price is $3.72.

In case you own OGI today, keep holding the stock. Market analysts also recommend a buy rating as the price could double by year-end 2021. British American Tobacco signed a strategic collaboration with OrganiGram in March 2021. The tobacco maker plans to augment its ongoing activities to expand the portfolio beyond nicotine.

The US$88.5 billion U.K. firm chose to collaborate with OrganiGram because of the latter’s cutting-edge R&D technologies, product innovation, and cannabis expertise. BAT will leverage Organigram’s first-hand experience to deepen its understanding of the rapidly expanding and evolving industry.

Growth catalysts

Don’t underestimate OrganiGram’s potential to make waves in the cannabis industry. The partnership with BAT, a leading consumer goods business with innovative product platforms should give it a competitive advantage. Its recent acquisition of the Edibles & Infusions Corporation should help capture a significant market share in Canada’s larger edibles market.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends OrganiGram Holdings. The Motley Fool recommends OrganiGram Holdings.

More on Cannabis Stocks

Caution, careful
Cannabis Stocks

I Wouldn’t Touch This TSX Stock With a 60-Foot Pole

I wouldn't touch Canopy Growth Corp (TSX:WEED) stock with a 60-foot pole.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why This Little-Known Cannabis Stock Could Double in 2024

This cannabis stock has already doubled this year since 52-week lows and could easily rise that much once more.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 420-Foot Pole

Down 87% from all-time highs, Cronos Group stock is a still a high-risk investment for long-term shareholders in 2024.

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth: Buy, Sell, or Hold?

Canopy Growth (TSX:WEED) stock should make a killing on U.S. expansion, but investors will need to be very patient.

Read more »

Marijuana plant and cannabis oil bottles isolated
Energy Stocks

3 Canadian Value Stocks to Buy Right Now

Undervalued Canadian stocks such as Secure Energy should be part of your shopping list in May 2024.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Here’s Why it’s Not Too Late to Buy Cronos Group Stock

The optimism about U.S. federal marijuana legalization and its anticipation are potent bullish triggers for the Canadian cannabis industry.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Canopy Growth Stock Is on a Tear: Is it a Good Buy Now? 

Canopy Growth (TSX:WEED) stock surged by 80% from news out of the U.S., but is enough there without the news…

Read more »

Marijuana plant and cannabis oil bottles isolated
Cannabis Stocks

Prediction: These Could Be the Best-Performing Cannabis Stocks Through 2030

Quality cannabis stocks such as Green Thumb and Cresco Labs are positioned to deliver outsized gains to shareholders in 2024…

Read more »